Description:
Aoxing Pharmaceutical Company, Inc., formerly China Aoxing Pharmaceutical Company, Inc. (China Aoxing), is a specialty pharmaceutical company specializing in research, development, manufacturing and distribution of a variety of narcotics and pain-management products. Its product line consists of prescription and over-the-counter pharmaceutical products. The Company has one operating subsidiary, Hebei Aoxing Pharmaceutical Co., Inc. (Hebei), which as of June 30, 2009, is 95% owned. Hebei is engaged in developing narcotics and pain management products, building its facilities and obtaining the requisite licenses from the Chinese Government. During the fiscal year ended June 30, 2009 (fiscal 2009), Hebei integrated into itself the business operations of Shijiazhuang Lerentang Pharmaceutical Company, Ltd. (LRT), a specialty pharmaceutical company focusing on pain related therapeutics, which had been an operating subsidiary acquired by Hebei in May 2008.

Officers and Directors:
Zhenjiang Yue Chairman of the Board, Chief Executive Officer
Age: 49
Bio & Compensation - Reuters
Hui Shao Chief Financial Officer
Age: 41
Bio & Compensation - Reuters
Hongyue Hao Acting Chief Financial Officer
Age: 38
Bio & Compensation - Reuters
Jun Min Director
Age: 49
Bio & Compensation - Reuters
John P. O'Shea Director
Age: 52
Bio & Compensation - Reuters
Howard David Sterling Director
Age: 68
Bio & Compensation - Reuters
Guozhu Xu Director

Contact:
444 Washington Blvd. Unit 2424
Jersey, NJ 07310
United States - Map
+1-201-4201075 (Phone)